424 related articles for article (PubMed ID: 12172555)
21. Nutrient content of diet affects the signaling activity of the insulin/target of rapamycin/p70 S6 kinase pathway in the African malaria mosquito Anopheles gambiae.
Arsic D; Guerin PM
J Insect Physiol; 2008 Aug; 54(8):1226-35. PubMed ID: 18634792
[TBL] [Abstract][Full Text] [Related]
22. Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex.
Nellist M; Sancak O; Goedbloed MA; Rohe C; van Netten D; Mayer K; Tucker-Williams A; van den Ouweland AM; Halley DJ
Eur J Hum Genet; 2005 Jan; 13(1):59-68. PubMed ID: 15483652
[TBL] [Abstract][Full Text] [Related]
23. Regulation of leucine uptake by tor1+ in Schizosaccharomyces pombe is sensitive to rapamycin.
Weisman R; Roitburg I; Nahari T; Kupiec M
Genetics; 2005 Feb; 169(2):539-50. PubMed ID: 15466417
[TBL] [Abstract][Full Text] [Related]
24. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
25. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
26. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.
El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ
Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473
[TBL] [Abstract][Full Text] [Related]
27. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.
Kapahi P; Zid BM; Harper T; Koslover D; Sapin V; Benzer S
Curr Biol; 2004 May; 14(10):885-90. PubMed ID: 15186745
[TBL] [Abstract][Full Text] [Related]
28. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.
Gao X; Pan D
Genes Dev; 2001 Jun; 15(11):1383-92. PubMed ID: 11390358
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cellular growth by the Drosophila target of rapamycin dTOR.
Zhang H; Stallock JP; Ng JC; Reinhard C; Neufeld TP
Genes Dev; 2000 Nov; 14(21):2712-24. PubMed ID: 11069888
[TBL] [Abstract][Full Text] [Related]
30. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
Garami A; Zwartkruis FJ; Nobukuni T; Joaquin M; Roccio M; Stocker H; Kozma SC; Hafen E; Bos JL; Thomas G
Mol Cell; 2003 Jun; 11(6):1457-66. PubMed ID: 12820960
[TBL] [Abstract][Full Text] [Related]
31. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
[TBL] [Abstract][Full Text] [Related]
32. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.
Kenerson H; Dundon TA; Yeung RS
Pediatr Res; 2005 Jan; 57(1):67-75. PubMed ID: 15557109
[TBL] [Abstract][Full Text] [Related]
33. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.
Kwiatkowski DJ
Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311
[TBL] [Abstract][Full Text] [Related]
34. A reliable cell-based assay for testing unclassified TSC2 gene variants.
Coevoets R; Arican S; Hoogeveen-Westerveld M; Simons E; van den Ouweland A; Halley D; Nellist M
Eur J Hum Genet; 2009 Mar; 17(3):301-10. PubMed ID: 18854862
[TBL] [Abstract][Full Text] [Related]
35. Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress.
Patel PH; Tamanoi F
J Cell Sci; 2006 Oct; 119(Pt 20):4285-92. PubMed ID: 17038544
[TBL] [Abstract][Full Text] [Related]
36. Tumour suppressors hamartin and tuberin: intracellular signalling.
Krymskaya VP
Cell Signal; 2003 Aug; 15(8):729-39. PubMed ID: 12781866
[TBL] [Abstract][Full Text] [Related]
37. Nutrient sensing in the mTOR/S6K1 signalling pathway.
Gulati P; Thomas G
Biochem Soc Trans; 2007 Apr; 35(Pt 2):236-8. PubMed ID: 17371247
[TBL] [Abstract][Full Text] [Related]
38. The tuberous sclerosis complex (TSC) pathway and mechanism of size control.
Potter CJ; Pedraza LG; Huang H; Xu T
Biochem Soc Trans; 2003 Jun; 31(Pt 3):584-6. PubMed ID: 12773160
[TBL] [Abstract][Full Text] [Related]
39. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.
Shah OJ; Wang Z; Hunter T
Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067
[TBL] [Abstract][Full Text] [Related]
40. Akt regulates growth by directly phosphorylating Tsc2.
Potter CJ; Pedraza LG; Xu T
Nat Cell Biol; 2002 Sep; 4(9):658-65. PubMed ID: 12172554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
